Orphan Drug COVID–19 Mitigation Act of 2022
Summary
Orphan Drug COVID-19 Mitigation Act of 2022 This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
Bill status
in committee
1 of 4 stages cleared
Introduction
Aug 2022
Committee Review
Floor Vote
President
Introduced Aug 2, 2022
Last action Aug 2, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Aug 2, 2022
House · Referred to committee
Referred to the House Committee on Energy and Commerce.
Aug 2, 2022
House · Introduced
Introduced in House
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Josh Gottheimer
DDemocratic
Co
Don Bacon
RRepublican
Co
Kurt Schrader
DDemocratic
Co
Madeleine Dean
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8641
Scope: US
Hi! I can help you understand HR 8641. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline